Ridloff Elena
SEC-identified person · CIK 1772518 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Director | filed 2021–2026 |
| Sionna Therapeutics, Inc. SION | CFO & Head of Corp. Dev. | filed 2025–2026 |
| Kronos Bio, Inc. KRON | Director | filed 2020–2025 |
| Acadia Pharmaceuticals INC ACAD | EVP and CFO | filed 2019–2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.